|Articles|September 2, 2001
- Pharmaceutical Technology-09-02-2001
- Volume 25
- Issue 9
Replacing the Animal Component in SerumEvaluating Raw Materials for Inclusion in Optimized Hybridoma Media
With the scarcity of CGMP facilities spurring a production crisis, manufacturers need to optimize their processes and formulations for individual hybridoma cell lines and production systems.
Advertisement
Articles in this issue
over 24 years ago
Six Sigma Can Give Contractors a Quality Advantageover 24 years ago
Industry Changes OTC Labels as Deadline Approachesover 24 years ago
A Report of the PQRI Workshop on Blend Uniformityover 24 years ago
Are You Ready for Global Manufacturing?over 24 years ago
Pharmaceutical Coverage and Costsover 24 years ago
Outsourcing OutlookNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma Industry Uncertainty in Wake of On/Off Greenland Tariffs
2
Integrating AI Discovery, Continuous Manufacturing, and Modern Regulatory Hurdles into Pharma Production
3
The Shift from Containment to Protection: Packaging Trends Impacting Pharma
4
FDA Releases Draft Guidance on Registering Pharmaceuticals for Human Use
5